Ferguson Shawn M
Department of Cell Biology, Yale University School of Medicine, New Haven, CT, 06510, United States; Program in Cellular Neuroscience, Neurodegeneration and Repair, Yale University School of Medicine, New Haven, CT 06510, United States.
Curr Opin Cell Biol. 2015 Aug;35:59-68. doi: 10.1016/j.ceb.2015.04.014. Epub 2015 May 15.
Lysosomes are becoming increasingly recognized as a hub that integrates diverse signals in order to control multiple aspects of cell physiology. This is illustrated by the discovery of a growing number of lysosome-localized proteins that respond to changes in growth factor and nutrient availability to regulate mTORC1 signaling as well as the identification of MiT/TFE transcription factors (MITF, TFEB and TFE3) as proteins that shuttle between lysosomes and the nucleus to elicit a transcriptional response to ongoing changes in lysosome status. These findings have been paralleled by advances in human genetics that connect mutations in genes involved in lysosomal signaling to a broad range of human illnesses ranging from cancer to neurological disease. This review summarizes these new discoveries at the interface between lysosome cell biology and human disease.
溶酶体日益被视为一个整合多种信号以控制细胞生理学多个方面的枢纽。越来越多定位于溶酶体的蛋白质被发现,它们可响应生长因子和营养可用性的变化来调节mTORC1信号传导,以及MiT/TFE转录因子(MITF、TFEB和TFE3)被鉴定为在溶酶体和细胞核之间穿梭以引发对溶酶体状态持续变化的转录反应的蛋白质,这些都说明了这一点。人类遗传学的进展也与此相呼应,这些进展将参与溶酶体信号传导的基因突变与从癌症到神经疾病等广泛的人类疾病联系起来。本综述总结了溶酶体细胞生物学与人类疾病交叉领域的这些新发现。